EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.1.3.56 | Alzheimer Disease |
27750211 |
INPP5D rs35349669 polymorphism with late-onset Alzheimer's disease: A replication study and meta-analysis. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
1
0 |
| 3.1.3.56 | Astrocytoma |
24358143 |
Identification of novel genetic alterations in samples of malignant glioma patients. |
ongoing research
unassigned |
2
0 |
| 3.1.3.56 | Ataxia |
26051944 |
Deletion of Inpp5a causes ataxia and cerebellar degeneration in mice. |
causal interaction
unassigned |
2
0 |
| 3.1.3.56 | Ataxia |
33792664 |
INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH. |
causal interaction
unassigned |
4
0 |
| 3.1.3.56 | Breast Neoplasms |
28448505 |
Polyphenolic extract of InsP 5-ptase expressing tomato plants reduce the proliferation of MCF-7 breast cancer cells. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 3.1.3.56 | Carcinoma |
19875416 |
Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples. |
ongoing research
unassigned |
3
0 |
| 3.1.3.56 | Carcinoma |
25759212 |
A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh. |
ongoing research
unassigned |
1
0 |
| 3.1.3.56 | Carcinoma |
28696004 |
Frequent loss of inositol polyphosphate-5-phosphatase in oropharyngeal squamous cell carcinoma. |
unassigned |
0 |
| 3.1.3.56 | Carcinoma |
31437542 |
Prognostic Value of Inositol Polyphosphate-5-Phosphatase Expression in Recurrent and Metastatic Cutaneous Squamous Cell Carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
1 |
| 3.1.3.56 | Carcinoma, Squamous Cell |
19875416 |
Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples. |
ongoing research
unassigned |
3
0 |
